Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
about
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseBiomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG TrialTranslating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity.Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial.Biomarkers for early detection of sickle nephropathyRenal dysfunction in patients with thalassaemiaDetermining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations.Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.Massive accidental overdose of hydroxyurea in a young child with sickle cell anemiaChronic kidney disease and albuminuria in children with sickle cell disease.High one year mortality in adults with sickle cell disease and end-stage renal disease.Genetic modifiers of sickle cell diseaseEffect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia.Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.Sickle cell nephropathy: challenging the conventional wisdom.New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy.Management of sickle cell disease in the community.Nocturnal enuresis in sickle cell disease.Emerging drugs for sickle cell anemia.Sickle cell disease: renal manifestations and mechanismsRoles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.Hydroxyurea (hydroxycarbamide) for sickle cell disease.Interventions for chronic kidney disease in people with sickle cell disease.Intravascular hemolysis and the pathophysiology of sickle cell disease.Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.Dose Selection Based on Modeling and Simulation for Rivipansel in Pediatric Patients Aged 6 to 11 Years With Sickle Cell Disease.The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.Diffusion tensor imaging MRI of sickle cell kidney disease: initial results and comparison with iron deposition.Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease.Clinical Features of β-Thalassemia and Sickle Cell Disease.Acute kidney injury in children with sickle cell disease-compounding a chronic problem.Glomerular hyperfiltration is strongly correlated with age in Congolese children with sickle cell anaemia.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q24187284-AA08B7B8-95D6-4372-8BCE-E87711E97314Q24198791-228BBE16-D041-4127-A06F-4E985D7D45F6Q24236018-751FD161-EA9A-4D2F-A82C-0307786918A6Q33789007-FDE52BA1-4EAF-4084-BB64-EC1A3E28BD03Q33871218-294F1DD5-3530-4440-BE62-D1D80D4889FBQ33909764-6C00E3FA-89E5-47F3-8D9F-2F9F9ABDD7B1Q34204444-722FAE59-74E3-4D71-94B8-7018A0B69238Q34601045-FA182208-754C-4E95-86D4-1FA05469633CQ34874858-F91BA213-2E74-4C84-98A4-26F467BC7A68Q35097294-C24B0047-6C32-446B-8AF9-6C876441906FQ35234959-28D7CE49-5476-445A-9A09-9580C026F854Q35278672-DB042807-34FC-4099-8238-8A6A0142E2EAQ35353627-2D5CC87E-6254-461F-9FA1-1F1BA5A3263AQ35985880-4DEDAE2D-8F68-4EFC-BBDE-B0F46601C54AQ36035191-F4E6F250-165A-4A9D-B3EE-DE9CA65C0F64Q36035471-AE937655-08CB-4B96-AA1E-1C5BE0CC0E82Q36094996-6A758E5C-13A0-4F57-91A0-2541EDD8DE49Q36155283-F5CCC6A7-02E9-4D10-8E18-B92BBA7E3BE6Q36358491-D7846500-1B20-4EA3-9A87-1587E615706FQ37825800-CE87AAAC-6FB7-487F-AA80-9450FFC9B690Q37928968-61654FED-2707-4D30-BFC6-8BB525BFB989Q38194789-35C13CFB-5B24-4458-BA30-981BE08F08FDQ38195064-7B627589-135F-4D3F-A011-7216F564C704Q38272226-F72C7786-43AB-4376-A76B-FCA491565E23Q38350669-739E29EE-89CE-4C65-AEC1-C9DE9471B162Q38682842-E9F1C271-DF3E-48BB-8851-210482970D41Q38692796-5E3FDEF4-FFBE-4841-93D7-3D232196FC83Q38696578-BC221E24-3D8F-4640-B31D-3E29197E712FQ39156028-9D4E3888-DBC2-425A-84FE-0EB0DD3EC047Q43461620-E7E3DC4F-9CAD-4BBA-9524-FA12A0094C12Q46342467-7FBAE180-4CEE-4436-9D9E-2ED986C99360Q47109784-D5986D68-93EF-4A93-A96B-16189F065FEAQ47129770-74D8BAD1-B901-481A-A790-1B08ED0B4AD7Q48090226-EF53FA09-7DB7-4881-9865-E974B8E4B7A1Q48209051-92ABA495-ADAB-419F-BB8A-12D4A05D9924Q49598847-2E426605-0AA0-4BC1-99C2-2E4BE43199D2Q50061141-92651329-2C37-4202-B011-651AB2B67A5BQ52779255-9EA3B7C7-52CF-4462-93E5-A97B638FA3D2Q52788322-14105C94-B028-4FCB-8032-C76BED5C15BBQ55427971-14FCDF8E-83E1-4553-ADE9-6EA9BF730D13
P2860
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@ast
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@en
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial.
@nl
type
label
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@ast
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@en
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial.
@nl
prefLabel
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@ast
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@en
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial.
@nl
P2093
P2860
P1476
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial
@en
P2093
BABY HUG Investigators
C Frederic Strife
Eglal Shalaby-Rana
James F Casella
John H Miller
Ofelia A Alvarez
Peter A Lane
Rathi V Iyer
Renee C Rees
Russell E Ware
P2860
P304
P356
10.1016/J.JPEDS.2009.06.060
P407
P577
2010-01-01T00:00:00Z